Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Aroplatin

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

liposomal oxaliplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview
Abstract Cisplatin cis-(diammine)dichloridoplatinum(II) (CDDP) is the first platinum-based complex approved by the food and drug… Expand
Review
2018
Review
2018
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
AbstractNanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer… Expand
  • figure 1
  • table 1
  • table 1
  • figure 2
Review
2013
Review
2013
Application of liposomal technologies for delivery of platinum analogs in oncology
Platinum-based chemotherapy, such as cisplatin, oxaliplatin, and carboplatin, is one of the most widely utilized classes of… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2010
Highly Cited
2010
The status of platinum anticancer drugs in the clinic and in clinical trials.
Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Review
2007
Review
2007
Broadening the clinical use of platinum drug–based chemotherapy with new analogues
  • L. Kelland
  • Expert opinion on investigational drugs
  • 2007
    • Corpus ID: 44788228
The three platinum-containing drugs that have been thus far approved by the FDA – cisplatin, carboplatin and oxaliplatin – have… Expand
2003
2003
268 A phase II trial of aroplatin (L-NDDP), a liposomal DACH platinum, in patients with metastatic colorectal cancer (CRC) - a preliminary report
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE